Endocrine Testing Market
Endocrine Testing Market Overview, Size, Industry Share, Growth, Trends, Report 2023-2028
According to the latest report by IMARC Group, titled “Endocrine Testing Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028,” offers a comprehensive analysis of the industry, which comprises insights on endocrine testing market. The report also includes competitor and regional analysis, and contemporary advancements in the global market.
The global endocrine testing market size reached US$ 10.4 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 16.4 Billion by 2028, exhibiting a growth rate (CAGR) of 7.7% during 2023-2028.
Endocrine testing pertains to diagnostic assessments that focus on the endocrine system, responsible for secreting hormones that regulate bodily functions such as metabolism, growth, and development. These tests typically analyze blood or urine samples to measure hormone levels, employing techniques such as immunoassay and mass spectrometry. The characteristics that make endocrine testing essential include its precision, reliability, and comprehensive scope in identifying hormone-related disorders like diabetes, thyroid malfunction, and adrenal insufficiency. The tests are crucial for early diagnosis, facilitating prompt and effective treatment strategies.
Get a Sample Copy of this Report: https://www.imarcgroup.com/endocrine-testing-market/requestsample
Market Trends:
The global market is primarily fueled by the escalating incidence of lifestyle-related disorders such as obesity and diabetes. In line with this, the rising geriatric population, susceptible to endocrine disorders, is also nudging the market forward. Moreover, the adoption of sedentary lifestyles is acting as a significant growth-inducing factor. Additionally, the growing awareness about preventive healthcare is pushing the demand for early diagnosis, positively impacting the market. Furthermore, advancements in testing technologies are streamlining diagnostic procedures. The market also gains from the accessibility of these tests across both online and offline healthcare facilities. Apart from this, favorable government initiatives in healthcare are lending support to the market. Some of the other factors contributing to the market growth include increasing healthcare expenditure, the integration of AI in diagnostics, a burgeoning middle-class population focusing on health, and ongoing research and development activities.
Explore Full Report with Table of Contents: https://www.imarcgroup.com/endocrine-testing-market
Competitive Landscape:
The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.
Abbott Laboratories
Agilent Technologies Inc.
Bio-Rad Laboratories Inc.
BioMerieux SA
DiaSorin S.p.A.
Hoffmann-La Roche AG (Roche Holding AG)
Laboratory Corporation of America Holdings
Quest Diagnostics Incorporated
Thermo Fisher Scientific Inc
Global Endocrine Testing Market Segmentation:
Our report has categorized the market based on region, test type, technology and end-use.
By Test Type:
Thyroid Test
Insulin Test
Human Chorionic Gonadotropin Test
Prolactin Test
Luteinizing Hormone Test
Progesterone Test
Others
By Technology:
Immunoassay
Tandem Mass Spectroscopy
Sensor Technology
LC-MS
Others
By End Use:
Hospitals
Ambulatory Care Centers
Clinical Laboratories
Others
By Region:
North America (United States, Canada)
Europe (Germany, France, United Kingdom, Italy, Spain, Others)
Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
Latin America (Brazil, Mexico, Others)
Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Other)
Key highlights of the report:
Market Performance (2017-2022)
Market Outlook (2023-2028)
Porter’s Five Forces Analysis
Market Drivers and Success Factors
SWOT Analysis
Value Chain
Comprehensive Mapping of the Competitive Landscape
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact US:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe:- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800